lung cancer
Conditions
Interventions
Intervention group(Phase 3):Symptom management intervention in patients with lung cancer-related cough from the perspective of whole-process management mode
Control group(Phase 3):General care
Observation Group 2 (Phase II):None
Sponsors
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Patients with stage III.b or IV lung cancer confirmed by pathological histology or cytology; (2) Age 18 ~ 80 years old; (3) The function of the heart, liver and kidney is basically normal; (4) Cough symptoms persist for more than 2 weeks; (5) Voluntarily participate in clinical research and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Expected survival period is less than 3 months; (2) Cough caused by tracheal, bronchial and pulmonary infections, bronchial foreign bodies, pulmonary tuberculosis, gastroesophageal reflux and other factors; (3) Pregnant or lactating women, or women planning to become pregnant; (4) Those with a history of uncontrollable mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough-related quality of life; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cough symptom;exercise self-efficacy; | — |
Countries
China
Contacts
Public ContactZhuoyan Chen
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital
Outcome results
None listed